# Catalent Pharma Solutions (Catalent Pharma Solutions Limited)

Private limited company registered in Swindon, classed under “Activities of head offices” and 1 other activity.

- Company number: 03761135
- Status: Active
- Type: Private limited company
- Incorporated: 28 April 1999
- Registered office: Frankland Road, Blagrove, Swindon, Wiltshire, SN5 8YG
- Location: Swindon, Wiltshire
- Activity: Activities of head offices

## Latest filed profit

No profit figure in its latest filed accounts.

Turnover, net assets, cash, staff, earlier years, ratios and owners are on the page for subscribers.

## Questions people ask

### What does Catalent Pharma Solutions do?

Private limited company registered in Swindon, classed under “Activities of head offices” and 1 other activity.

### How much turnover does Catalent Pharma Solutions make?

Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/catalent-pharma-solutions-03761135

### Is Catalent Pharma Solutions profitable?

Catalent Pharma Solutions's profit isn't public: small companies may file without a profit and loss account.

### Who runs and owns Catalent Pharma Solutions?

Its directors are Ramon Javier Ceron, Robert Derry, Colin Allister James Dick, Aristippos Gennadios, Ricky Wayne Hopson. Its owners are shown to subscribers.

### Where is Catalent Pharma Solutions based?

Its registered office is Frankland Road, Blagrove, Swindon, Wiltshire, SN5 8YG, in Swindon, Wiltshire.

### When was Catalent Pharma Solutions founded?

Catalent Pharma Solutions Limited was incorporated on 28 April 1999.

### Is Catalent Pharma Solutions still trading?

The register lists Catalent Pharma Solutions Limited as active.

## Timeline

Recent filings and changes at Companies House.

- 2026-09-17: Appointment of Mr. Robert Derry as a director on 1 July 2026
- 2026-07-15: Termination of appointment of Kate Toller Barnett as a director on 1 July 2026
- 2026-05-11: Full accounts made up to 31 December 2025
- 2025-05-15: Change of details for Catalent, Inc. as a person with significant control on 18 December 2024
- 2025-04-17: Appointment of Mr Colin Allister James Dick as a director on 1 April 2025
- 2025-04-17: Appointment of Mrs Kate Toller Barnett as a director on 1 April 2025
- 2025-01-15: Full accounts made up to 30 June 2024
- 2025-01-13: Current accounting period extended from 30 June 2025 to 31 December 2025
- 2024-12-28: Resolutions (and 5 more like it since 21 June 2010)
- 2024-07-11: Full accounts made up to 30 June 2023
- 2023-12-07: Director's details changed for Mr Ricky Wayne Hobson on 7 December 2023
- 2023-12-07: Appointment of Mr Ricky Wayne Hobson as a director on 4 December 2023
- 2023-11-03: Appointment of Mr. Ramon Javier Ceron as a director on 2 October 2023
- 2023-11-01: Termination of appointment of Jonathan Arnold as a director on 29 September 2023
- 2023-11-01: Termination of appointment of Steven Fasman as a director on 13 September 2023
- 2023-08-23: Appointment of Mr Steven Fasman as a director on 16 August 2023
- 2023-06-06: Full accounts made up to 30 June 2022
- 2023-05-03: Termination of appointment of Thomas Castellano as a director on 21 April 2023
- 2022-06-29: Statement of capital following an allotment of shares on 29 June 2022 · GBP 41,933,689.75 (and 2 more like it since 10 November 2010)
- 2022-06-22: Appointment of Mr Thomas Castellano as a director on 31 May 2022
- 2022-06-21: Termination of appointment of Alessandro Maselli as a director on 31 May 2022
- 2022-04-07: Full accounts made up to 30 June 2021
- 2021-11-18: Termination of appointment of Alex Reed as a secretary on 22 October 2021
- 2020-12-19: Full accounts made up to 30 June 2020
- 2020-07-09: Full accounts made up to 30 June 2019

---

Source: Companies House filings (Open Government Licence v3.0). Figures are as filed; nothing is estimated. Page: https://firmfacts.co/company/catalent-pharma-solutions-03761135